Showing 2 of 2 recruiting trials for “Alveolar rhabdomyosarcoma”
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas
👨⚕️ Svetlana Kulyova, MD, Phd, Head of Children's Oncology Department📍 1 site📅 Started May 2021View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →